Skip to main content
رجوع
UCBJY logo

UCB S.A.

جودة البيانات: 100%
UCBJY
OTC Healthcare Biotechnology
KWD 144.63
▲ KWD 3.01 (2.13%)
القيمة السوقية: 55.06B
مُدرج أيضًا باسم UCBJF OTC
نطاق اليوم
KWD 143.81 KWD 145.91
نطاق 52 أسبوعًا
KWD 71.16 KWD 168.76
حجم التداول
3,348
متوسط 50 يوم / 200 يوم
KWD 152.79 / KWD 129.82
الإغلاق السابق
KWD 141.62

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E 36.8 0.4
P/B 5.1 2.9
ROE % 14.3 3.7
Net Margin % 20.1 3.9
Rev Growth 5Y % 6.5 10.0
D/E 0.2 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 11.651
KWD 11.292 – KWD 11.929
 13 B 1
FY2029 KWD 10.159
KWD 9.846 – KWD 10.401
 12 B 1
FY2028 KWD 8.569
KWD 8.305 – KWD 8.774
 11 B 1

النقاط الرئيسية

Revenue grew 6.51% annually over 5 years — modest growth
Earnings grew 40.52% over the past year
ROE of 14.33% — decent returns on equity
Net margin of 20.13% shows strong profitability
Debt/Equity of 0.21 — conservative balance sheet
Generating 1.81B in free cash flow

النمو

Revenue Growth (5Y)
6.51%
Revenue (1Y)20.86%
Earnings (1Y)40.52%
FCF Growth (3Y)101.55%

الجودة

Return on Equity
14.33%
ROIC6.41%
Net Margin20.13%
Op. Margin15.06%

الأمان

Debt / Equity
0.21
Current Ratio1.38
Interest Coverage9.11

التقييم

P/E Ratio
36.79
P/B Ratio5.07
EV/EBITDA49.16
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 20.86% Revenue Growth (3Y) 18.99%
Earnings Growth (1Y) 40.52% Earnings Growth (3Y) 108.88%
Revenue Growth (5Y) 6.51% Earnings Growth (5Y) 9.06%
Profitability
Revenue (TTM) 7.44B Net Income (TTM) 1.50B
ROE 14.33% ROA 8.25%
Gross Margin 71.14% Operating Margin 15.06%
Net Margin 20.13% Free Cash Flow (TTM) 1.81B
ROIC 6.41% FCF Growth (3Y) 101.55%
Safety
Debt / Equity 0.21 Current Ratio 1.38
Interest Coverage 9.11 Dividend Yield 0.01%
Valuation
P/E Ratio 36.79 P/B Ratio 5.07
P/S Ratio 7.41 PEG Ratio 0.76
EV/EBITDA 49.16 Dividend Yield 0.01%
Market Cap 55.06B Enterprise Value 55.06B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 7.44B 6.15B 5.25B 5.52B 5.78B
Net Income 1.50B 1.07B 343.00M 418.00M 1.06B
EPS (Diluted) 3.86 2.74 0.88 1.08 2.73
Gross Profit 5.29B 4.40B 3.55B 3.84B 4.34B
Operating Income 1.12B 1.32B 604.00M 585.00M 1.28B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18.15B 17.35B 15.54B 15.87B 14.21B
Total Liabilities 7.29B 7.32B 6.56B 6.80B 5.82B
Shareholders' Equity 10.86B 10.03B 8.98B 9.06B 8.39B
Total Debt 2.24B 3.03B 3.04B 2.90B 2.12B
Cash & Equivalents 2.25B 1.57B 861.00M 899.00M 1.26B
Current Assets 6.05B 4.79B 3.44B 3.30B 3.71B
Current Liabilities 4.40B 3.53B 2.62B 3.11B 2.82B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#851 of 1024
28

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026